S2EP4: That's a Check I'm Not Willing To Take with Marissa Fayer

She had nine commercial partners, FDA clearance, and a 25-year medtech track record. Still an investor stopped her mid-pitch to ask whether breast cancer was “still a thing.”In this episode of The Capital Flex, I sit down with Marissa Fayer, engineer, operator, and CEO of Deep Look Medical, an FDA-cleared imaging software company helping radiologists visualize soft tumors in dense tissue with a single click.Marissa shares what it looked like to raise capital through one of the toughest fundraising markets in decades while building in women’s health and medical imaging. She opens up about the investor who asked what her husband does, the pitch room that stayed silent after a dismissive question about breast cancer, and why she walked away from money she needed because the room told her everything she needed to know.The conversation digs into fundamental mismatches in women’s health, why medtech  companies often struggle to fit venture mandates, and the difference between raising money strategically versus raising for ego. Marissa also shares lessons from a costly infrastructure decision, how pedigree hires can fail early-stage companies, and why women’s health founders need to stop speaking only inside women’s health echo chambers.The episode closes with a powerful conversation about consumer demand, clinical adoption, and why patients asking their doctors better questions may be one of the biggest drivers of change in healthcare.Key Takeaways:What happens when an investor decides the problem you are solving is not realInside the mismatch between women’s health startups and venture fund expectationsWhy founders need experienced operators and board members around them earlyHow consumer demand is reshaping healthcare adoption from the ground upWhat women’s health founders miss when they only speak inside the existing ecosystemMy Reflection & Challenge:Marissa walked out of a pitch meeting, while her company needed the capital,  because she was not willing to sit inside an investor group that let bad behavior persist without consequence. That is not pride. That is knowing which rooms will cost you more than the money is worth. Not every founder is in a position to do that, but every founder can get clearer on where the line is before they walk in.This Week's Challenge:The next time an investor asks a question that has nothing to do with your business: what is your one-word answer, and how fast can you get back to the pitch?Where are you still chasing fund fit that structurally does not exist for your stage, your model or your category and what would it free up if you stopped?Links and Resources: https://www.deeplookmedical.com/If you enjoyed this conversation, follow The Capital Flex, leave a rating, and share this episode with a founder who needs it.And if you’re looking for a more candid space to talk fundraising, power, and building inside systems not designed for you, stay close. The conversation continues.Production and Administration work completed by Smart Podcast Solutions and Elevate Business Solutions.